Sanofi-aventis Revenue and Competitors
Estimated Revenue & Valuation
- Sanofi-aventis's estimated annual revenue is currently $43.8M per year.
- Sanofi-aventis's estimated revenue per employee is $201,000
Employee Data
- Sanofi-aventis has 218 Employees.
- Sanofi-aventis grew their employee count by 5% last year.
Sanofi-aventis's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior Medical Director | Reveal Email/Phone |
2 | Strategy and Partnering, Director Digital Alliances | Reveal Email/Phone |
3 | Senior Manager - MSAT | Reveal Email/Phone |
4 | KSOL NA/LATAM | Reveal Email/Phone |
5 | Senior Partner | Reveal Email/Phone |
6 | Medical portfolio management | Reveal Email/Phone |
7 | Senior Associate, Regulatory Operations | Reveal Email/Phone |
8 | Scientist | Reveal Email/Phone |
9 | Lab Head/Distinguished Scientist | Reveal Email/Phone |
10 | Senior Medical Science Liaison | Reveal Email/Phone |
Sanofi-aventis Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.6M | 33 | 32% | N/A | N/A |
#2 | $38M | 189 | 6% | N/A | N/A |
#3 | $6.6M | 33 | 22% | N/A | N/A |
#4 | $4180M | 15242 | 1% | $550M | N/A |
#5 | $17.5M | 87 | 50% | N/A | N/A |
#6 | $6.7M | 125 | -37% | $199.6M | N/A |
#7 | $10.9M | 54 | 15% | N/A | N/A |
#8 | $15.3M | 76 | 33% | N/A | N/A |
#9 | $128.6M | 640 | 16% | N/A | N/A |
#10 | $18.7M | 93 | 21% | N/A | N/A |
What Is Sanofi-aventis?
Sanofi-Aventis U.S. LLC is a pharmaceuticals company based out of 55 Corporate Dr, Bridgewater, New Jersey, United States.
keywords:N/AN/A
Total Funding
218
Number of Employees
$43.8M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sanofi-aventis News
2022-04-20 - Artesunate Tablet Market Growth and Demands Analysis from ...
Artesunate Tablet Market Growth and Demands Analysis from 2022-2028 | Fosun Pharma (Guilin), Ipca Laboratories, Sanofi Aventis.
2022-04-19 - Global Biopharmaceuticals Market 2022 Business ...
Roche; Amgen; AbbVie; Sanofi-Aventis; Johnson & Johnson; Pfizer; Novo Nordisk; Eli Lilly; Novartis; Merck; Sun; 3sbio; Changchun High Tech...
2022-03-30 - Sanofi-aventis Reports Expanded Approval Of Dupixent In Canada To Include
Children Aged Six To 11
(RTTNews) - Sanofi-aventis Canada Inc. announced the expanded approval of Dupixent as an add-on maintenance treatment in patients aged six...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $31.3M | 237 | -14% | N/A |
#2 | $67.9M | 246 | 3% | N/A |
#3 | $74.8M | 271 | -6% | N/A |
#4 | $55.4M | 280 | -4% | N/A |
#5 | $101.6M | 301 | 6% | N/A |